EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity

Anat Aharon, Ayelet Dangot, Fadi Kinaani, Mor Zavaro, Lian Bannon, Tali Bar-Lev, Anat Keren-Politansky, Irit Avivi, Giris Jacob

International Journal of Molecular Sciences · 21.03.2023 · 24 (6) · 5918

DOI: 10.3390/ijms24065918 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.03.2023. Verfasst von Anat Aharon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Research Laboratory, Hematology Department, Tel-Aviv Sourasky Medical Center, Tel Aviv 69978, Israel. Hauptthemen laut MEDLINE: COVID-19, Extracellular Vesicles, Exosomes. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe COVID-19 infections present with cytokine storms, hypercoagulation, and acute respiratory distress syndrome, with extracellular vesicles (EVs) being involved in coagulation and inflammation. This study aimed to determine whether coagulation profiles and EVs reflect COVID-19 disease severity. Thirty-six patients with symptomatic COVID-19 infection with mild/moderate/severe disease (12 in each group) were analyzed. Sixteen healthy individuals served as controls. Coagulation profiles and EV characteristics were tested by nanoparticle tracking analysis (NTA), flow cytometry, and Western blot. While coagulation factors VII, V, VIII, and vWF were comparable, significant differences were found in patients’ D-Dimer/fibrinogen/free protein S levels compared to controls. Severe patients’ EVs displayed higher percentages of small EVs (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Extracellular VesiclesExosomesHumansBiomarkersInflammationPatient Acuity

Stichwörter der Autor:innen

COVID-19extracellular vesicles (EVs)inflammationthrombogenicity

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Hematology Research Laboratory, Hematology Department, Tel-Aviv Sourasky Medical Center, Tel Aviv 69978, Israel.
  • The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.
  • Department of Medicine F, Tel-Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
  • Coagulation Laboratory, Rambam Health Care Campus, Haifa 3109601, Israel.
  • Hematology Department, Tel-Aviv Sourasky Medical Center, Tel Aviv 69978, Israel.
  • Recanati Center, Tel-Aviv Sourasky Medical Center, Tel Aviv 69978, Israel.

Zitieren

APA

Aharon, A., Dangot, A., Kinaani, F., Zavaro, M., Bannon, L., Bar-Lev, T., Keren-Politansky, A., Avivi, I., & Jacob, G. (2023). Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity. International Journal of Molecular Sciences, 24(6), 5918. https://doi.org/10.3390/ijms24065918

Vancouver

Aharon A, Dangot A, Kinaani F, Zavaro M, Bannon L, Bar-Lev T, et al. Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity. International Journal of Molecular Sciences. 2023;24(6):5918. doi:10.3390/ijms24065918

BibTeX
@article{Aharon2023,
  author = {Aharon, Anat and Dangot, Ayelet and Kinaani, Fadi and Zavaro, Mor and Bannon, Lian and Bar-Lev, Tali and Keren-Politansky, Anat and Avivi, Irit and Jacob, Giris},
  title = {Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {6},
  pages = {5918},
  doi = {10.3390/ijms24065918}
}
Kostenlos starten →